The National Renal Complement Therapeutics Centre opened in 2016. We specialise in atypical haemolytic uraemic syndrome and C3 glomerulopathy.
Our collective expertise encompasses clinical, diagnostic and research staff based within Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. We offer advice on the diagnosis and management of these rare conditions. Specifically, we provide diagnostic support to clinicians in England and Scotland and implement NICE policy for use of eculizumab and ravulizumab in aHUS and clinical commissioning policy for use of eculizumab in C3G in England. Patients are generally managed by their local nephrologist but patients can be seen in our specialist clinic in Newcastle or have a consultation with members of our clinical team by telephone or video-call if preferred.
Newcastle upon Tyne
hospitals nhs foundation trust
We’re proud to serve the people of the North East but we’re so much more than a group of top class local hospitals. Rated ‘Outstanding’ by the Care QualityCommission, the Newcastle Hospitals are recognised nationally and internationally as a centre of healthcare excellence, with almost a third of our patients coming from outside Tyne & Wear to benefit from our wide range of specialist services.
For more information visit: http://www.newcastle-hospitals.org.uk/.